{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:53:14Z","timestamp":1792183994158,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s00393-007-0177-1","type":"journal-article","created":{"date-parts":[[2007,6,11]],"date-time":"2007-06-11T12:10:41Z","timestamp":1181563841000},"page":"317-325","source":"Crossref","is-referenced-by-count":6,"title":["Kristallarthropathien \u2013 alt, aber wichtig","Crystal-induced arthritis \u2013 old but important"],"prefix":"10.1007","volume":"66","author":[{"given":"M.","family":"Winzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gr\u00e4\u00dfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,7,12]]},"reference":[{"key":"177_CR1","first-page":"2403","volume":"29","author":"Arromdee","year":"2002","unstructured":"Arromdee E, Michet CJ, Crowson CS et al. (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29: 2403\u20132406","journal-title":"J Rheumatol"},{"key":"177_CR2","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","volume":"353","author":"Becker","year":"2005","unstructured":"Becker MA, Schumacher HR, Wortmann RL et al. (2005) Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 353: 2450\u20132461","journal-title":"N Engl J Med"},{"key":"177_CR3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.berh.2006.05.006","volume":"20","author":"Chen","year":"2006","unstructured":"Chen LX, Schumacher HR (2006) Gout: can we create an evidence-based systematic approach to diagnosis and management? Best Pract Res Clin Rheumatol 20: 673\u2013684","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"177_CR4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00002281-200005000-00013","volume":"12","author":"Fam","year":"2000","unstructured":"Fam AG (2000) What is new about crystals other than monosodium urate? Curr Opin Rheumatol 12: 228\u2013234","journal-title":"Curr Opin Rheumatol"},{"key":"177_CR5","first-page":"2285","volume":"26","author":"Fernandez","year":"1999","unstructured":"Fernandez C, Noguera R, Gonzalez JA, Pascual E (1999) Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide. J Rheumatol 26: 2285\u20132286","journal-title":"J Rheumatol"},{"key":"177_CR6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/art.21499","volume":"54","author":"Graessler","year":"2006","unstructured":"Graessler J, Graessler A, Unger S et al. (2006) Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 54: 292\u2013300","journal-title":"Arthritis Rheum"},{"key":"177_CR7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0049-0172(90)90070-V","volume":"19","author":"Groff","year":"1990","unstructured":"Groff GD, Franck WA, Raddatz DA (1990) Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Semin Arthritis Rheum 19: 329\u2013336","journal-title":"Semin Arthritis Rheum"},{"key":"177_CR8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00002281-200105000-00013","volume":"13","author":"Halverson","year":"2001","unstructured":"Halverson PB, Derfus BA (2001) Calcium crystal-induced inflammation. Curr Opin Rheumatol 13: 221\u2013224","journal-title":"Curr Opin Rheumatol"},{"key":"177_CR9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/431592","volume":"41","author":"Hung","year":"2005","unstructured":"Hung IF, Wu AK, Cheng VC et al. (2005) Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. Clin Infect Dis 41: 291\u2013300","journal-title":"Clin Infect Dis"},{"key":"177_CR10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/ajkd.2002.33911","volume":"40","author":"Kramer","year":"2002","unstructured":"Kramer HM, Curhan G (2002) The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988\u20131994. Am J Kidney Dis 40: 37\u201342","journal-title":"Am J Kidney Dis"},{"key":"177_CR11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00002281-200105000-00014","volume":"13","author":"Maldonado","year":"2001","unstructured":"Maldonado I, Reginato AM, Reginato AJ (2001) Familial calcium crystal diseases: what have we learned? Curr Opin Rheumatol 13: 225\u2013233","journal-title":"Curr Opin Rheumatol"},{"key":"177_CR12","first-page":"1306","volume":"28","author":"Moriwaki","year":"2001","unstructured":"Moriwaki Y, Yamamoto T, Takahashi S et al. (2001) Spot urine uric acid to creatinine ratio used in the estimation of uric acid excretion in primary gout. J Rheumatol 28: 1306\u20131310","journal-title":"J Rheumatol"},{"key":"177_CR13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/art.22232","volume":"55","author":"Perez-Ruiz","year":"2006","unstructured":"Perez-Ruiz F, Atxotegi J, Hernando I et al. (2006) Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study. Arthritis Rheum 55: 786\u2013790","journal-title":"Arthritis Rheum"},{"key":"177_CR14","first-page":"974","volume":"14","author":"Roseff","year":"1987","unstructured":"Roseff R, Wohlgethan JR, Sipe JD, Canoso JJ (1987) The acute phase response in gout. J Rheumatol 14: 974\u2013977","journal-title":"J Rheumatol"},{"key":"177_CR15","first-page":"CD006190","volume":"4","author":"Schlesinger","year":"2006","unstructured":"Schlesinger N, Schumacher R, Catton M, Maxwell L (2006) Colchicine for acute gout. Cochrane Database Syst Rev 4: CD006190","journal-title":"Cochrane Database Syst Rev"},{"key":"177_CR16","doi-asserted-by":"crossref","unstructured":"Schueller-Weidekamm C, Schueller G, Aringer M et al. (2007) Impact of sonography in gouty arthritis: Comparison with conventional radiography, clinical examination, and laboratory findings. Eur J Radiol (Epub ahead of print)","DOI":"10.1016\/j.ejrad.2006.12.005"},{"key":"177_CR17","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/ar1909","volume":"Ther","author":"Terkeltaub","year":"2006","unstructured":"Terkeltaub R, Bushinsky DA, Becker MA (2006) Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. Arthritis Res Ther (Suppl 1) 8: S4","journal-title":"Arthritis Res"},{"key":"177_CR18","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.332.7553.1315","volume":"332","author":"Underwood","year":"2006","unstructured":"Underwood M (2006) Diagnosis and management of gout. BMJ 332: 1315\u20131319","journal-title":"BMJ"},{"key":"177_CR19","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Bardin T et al. (2006) EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65: 1312\u20131324","journal-title":"Ann Rheum Dis"},{"key":"177_CR20","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","volume":"65","author":"Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Pascual E et al. (2006) EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65: 1301\u20131311","journal-title":"Ann Rheum Dis"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-007-0177-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-007-0177-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-007-0177-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:29:39Z","timestamp":1559060979000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-007-0177-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["177"],"URL":"https:\/\/doi.org\/10.1007\/s00393-007-0177-1","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}